Press Room

Press Releases

In the News

Logo & Resources Library

Recent Press Releases

LRA Highlights Full Continuum of Lupus Research at ACR Convergence 2020

30+ presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways Results from...

Lupus Research Alliance Announces Seven Recipients of the 2020 Lupus Innovation Award

NEW YORK, NY, November 9, 2020. The Lupus Research Alliance proudly announced today the 2020 Lupus Innovation Award recipients....

The Lupus Research Alliance Presents 2020 Lupus Insight Prize Recipient – Dr. Jane Salmon

New York, NY. September 25, 2020 -- The Lupus Research Alliance presented its 2020 Lupus Insight Prize to Jane...

LRA Applauds GSK on Positive Phase 3 Study of Benlysta® in Lupus Nephritis

September 16, 2020 NEW YORK, NY. The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week’s...

LRA Statement: Potential Lupus Nephritis Drug Voclosporin Granted Priority Review by the U.S. FDA

NEW YORK, NY. July 22, 2020. The Lupus Research Alliance congratulates Aurinia Pharmaceuticals Inc. on acceptance of its NDA...

Lupus Research Alliance Announces 10 Recipients of New Award in Partnership with Bristol Myers Squibb

NEW YORK, NY. July 14, 2020 -- The Lupus Research Alliance (LRA) is pleased to announce the recipients of...

COVID-19 Caused Hydroxychloroquine Issues for Third of Lupus Patients, New LRA Survey Finds

NEW YORK, NY, May 28, 2020. More than one third of people with lupus experienced significant issues filling their...

Lupus Therapeutics, Affiliate of Lupus Research Alliance, Developing a Study Focused on Lupus Patients and COVID-19

New York, NY, April 7, 2020 – Lupus Therapeutics, the clinical trial affiliate of the Lupus Research Alliance (LRA),...

MARCH 26 STATEMENT: Lupus Research Alliance Puts Plaquenil (Hydroxychloroquine) Shortage into Perspective for Lupus Community

March 26, 2020 The Lupus Research Alliance (LRA), the world’s leading research organization dedicated to lupus research, continues to watch...

New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis

December 17, 2019 The Lupus Research Alliance is thrilled to share exciting news from GSK that Benlysta (belimumab) demonstrated positive...

Lupus Research Alliance 2019 Breaking Through Gala Raises $3 Million for Lupus Research

November 26, 2019 – New York, NY – The Lupus Research Alliance (LRA) 2019 Breaking Through Gala gathered more...

Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting

NEW YORK, NY – November 11. The Lupus Research Alliance (LRA) congratulates AstraZeneca on new positive results from the...